logo
Warning to anyone who sees blackbirds in their garden this summer over deadly virus decimating critical species

Warning to anyone who sees blackbirds in their garden this summer over deadly virus decimating critical species

The Sun17-05-2025

A WARNING has been issued to gardeners to look out for blackbirds this summer.
Almost half of the species' population has been decimated from a mosquito-borne disease.
1
Scientists are now calling on UK households with gardens to monitor blackbird population.
Anyone whose garden gets frequented by the bird has been asked to participate in a national research.
The deadly Usutu virus has reduced the blackbird population in Greater London by 40 per cent since 2020.
The disease is spreading rapidly across the UK, especially in the southern parts of England.
Now, there are concerns that more mosquito-borne diseases could spread in the future.
Dr Arran Folly from the Animal and Plant Health Agency (APHA) told BBC: "We've seen that the virus has spread further than we thought it might do, and it's persisted.
"Blackbirds specifically are quite susceptible to the virus.
"It gives an indication that in the future we might get other viruses that are transmitted by mosquitoes emerging in the UK."
Scientists have urged the public to note how many blackbirds they see within a particular time frame and enter that information into a survey.
You will also be asked to look out for any behaviours such as foraging for food.
'Intense' mystery symptoms with baseball-sized swelling in mosquito bite victims leave doctors stumped
Participants are encouraged to complete one survey per week.
The British Trust for Ornithology said: "The Blackbirds in Gardens project will help us understand how Blackbirds use gardens, and the potential effects of the Usutu virus on their population in the UK.
"If you have access to a garden, have an interest in garden birds and can recognise a Blackbird by sight, then this survey could be for you!"
The survey will run until September and takes 15 minutes to complete.
It comes as gardeners have been warned to postpone one common task during Spring.
The warning has even been backed by Sir David Attenborough.
Top 5 Spring Gardening Jobs
*If you click a link in this boxout, we may earn affiliate revenue
Nick Grey, Gtech Inventor and CEO shared the tasks to crack on with as Spring arrives.
1. Clean your garden
Make sure to clear away all leaves, soil and plant debris from your patios and flower beds; this creates a healthier environment for new growth, especially as we get into the summer months. Gtech's Garden Safety Kit includes durable gardening gloves and safety glasses; perfect for comfortability whilst tackling those outdoor tasks.
2. Weeding
Early Spring is the best time to tackle weeds; if you can introduce some regular weeding into your routine, you can guarantee a tidy garden all year round.
3. Hedge maintenance
Spring is the ideal time to tidy up overgrown hedges and shrubs, as regular trimming ensures healthy growth and reduces pest issues. Using a tool like the Gtech Lightweight Hedge Trimmer can help to keep your greenery looking sharp and neat.
4. Composting
Starting a compost heap this spring is a pro-active, cost-effective way to harness nutritious soil for your plants and recycle organic waste that will benefit the overall health of your greenery and foliage.
5. Look after your lawn
Lawn care is hugely important in assuring your garden stays looking beautiful. Make sure to rake away any excess leaves and trim your grass routinely.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

One million blood donors needed to meet demand and avoid 'red alert' shortage, NHS warns
One million blood donors needed to meet demand and avoid 'red alert' shortage, NHS warns

Sky News

time27 minutes ago

  • Sky News

One million blood donors needed to meet demand and avoid 'red alert' shortage, NHS warns

The NHS has warned the UK needs one million regular blood donors to maintain supply and avoid a "red alert" - which means supplies are so low there is a threat to public safety. Last July, officials issued an "amber alert" for stocks of O negative and O positive blood after cyberattacks hit London hospitals. NHS Blood and Transplant (NHSBT) said blood stocks have remained low since. Dr Jo Farrar, NHSBT chief executive, said: "Our stocks over the past 12 months have been challenging. If we had a million regular donors, this would help keep our stocks healthy - you'd truly be one in a million. "Please book an appointment today, experience how good it feels to save lives, and come and do it again in a few months." The NHSBT added just 2% of the population - under 800,000 people - sustained the whole of England's blood supply over the past 12 months. It said there is a "critical" need for more donors who have O negative blood, the universal type used in emergencies or when a patient's blood type is unknown. It is typically carried by air ambulances and emergency vehicles - and makes up around 16% of hospital blood orders. There is also a need for more black donors, who are more likely to have specific blood types which can help treat people with sickle cell disease. Health Minister Baroness Merron said: "The NHS is in urgent need of more lifesaving blood donors from all backgrounds. "We are working alongside NHS Blood and Transplant to make donating blood easier than ever before, opening up new donor centres and making appointments available closer to home." Women can donate blood once every four months and men can do so once every three.

More than 1,000 doctors urge MPs to vote against assisted dying bill
More than 1,000 doctors urge MPs to vote against assisted dying bill

Sky News

time30 minutes ago

  • Sky News

More than 1,000 doctors urge MPs to vote against assisted dying bill

More than 1,000 doctors have written to MPs urging them to vote against the assisted dying bill, calling it a "real threat to both patients and the medical workforce". The bill - which is due to be voted on by MPs for a final time on 20 June - would allow terminally ill patients from England and Wales to end their lives "on their own terms", providing they have a life expectancy of six months or less. A separate bill is currently passing through the Scottish parliament. But doctors from across the NHS have written to MPs, warning them of their "serious concerns". Notable signatories include Sir John Burn, a geneticist who has led decades of cancer research, Sir Shakeel Qureshi, who was knighted for his work in paediatric cardiology, Professor Aileen Keel, the former deputy chief medical officer for Scotland, and Baroness Finlay, a Welsh doctor, professor of palliative medicine and member of the House of Lords. The letter is signed by four doctors who hold OBEs, two who have MBEs, and one CBE. The letter says that while a debate is needed on end of life care, "this bill is not the answer". It raises concerns that not enough evidence has been heard from doctors, people with disabilities and other marginalised groups. "This bill will widen inequalities, it provides inadequate safeguards and, in our collective view, is simply not safe," it goes on to say, calling it a "deeply flawed bill". 1:40 Professor Colin Rees, a member of the Royal College of Physicians working group on assisted dying, said it was the "single most important piece of healthcare legislation in 50 or 60 years". "It will have very profound consequences for the future and many doctors are really concerned that members of parliament are not hearing the views of the medical profession." He said many doctors who remain neutral, or who even support the principle of assisted dying, remain concerned about the bill. "We don't think it's a bill that is safe, that protects patients, protects families, and protects the medical workforce." What stage are the two assisted dying bills at now? The Terminally Ill Adults (End of Life) Bill passed the House of Commons with a majority of 55 in November. Scotland's Assisted Dying for Terminally Ill Adults (Scotland Bill) pass with a 14 majority in May. But the legislation has not been without controversy, with 150 amendments made to get it through the first stage. The bill will return to the House of Commons for a third reading this Friday. If voted through by MPs it will then proceed to the House of Lords. 'No safeguards against coercion' One of the areas of concern raised by the medics was the inability to properly identify patients at risk of coercive control. "Vulnerable patients are at risk of coercion with women, victims of domestic abuse, and the elderly at particular risk," the letter says. It also warned it would widen social inequalities, with patients who do not have the resources for a comfortable death more likely to opt for assisted dying. "People who struggle to pay for heating or care or wish to preserve their assets for their children are at high risk of choosing to die if the option is available and the alternative is more difficult." Data from the Annual Report of Dying With Dignity from Oregon in 2024 found 9.3% of those people who choose assisted deaths do so for financial reasons. 'Doctors get it wrong 40% of the time' Concerns have also been raised around the inaccuracies of medical prognosis. "Research demonstrates that doctors get prognosis wrong around 40% of the time," the letter says. "As such, patients may end up choosing an assisted death and losing what could have been happy and fulfilling months or years of life." 1:50 The bill is also a risk to families, the letter says, as it does not require doctors to speak with family members. "A close relative may know nothing until they get a call to arrange collection of their relative's body," it says, adding that there is no mechanism for a family member to raise concerns about a request. The letter also addressed the potential impact on the medical workforce. Evidence from the Netherlands suggests "doctors feel pressurised when dealing with patient requests for assisted deaths, meaning that doctors may end up having involvement despite it being against their principles, because they want to help their patients". Doctors' letter highlight concerns about the risk to: Patients Does not necessitate treatment of depression or other remediable factors; does not protect against risk of coercion, particularly for women and the elderly; does not ensure that the assessment panel must meet the patient; will widen social inequalities, adversely affecting the socioeconomically deprived; does not take account of the inadequacies of assessing medical prognosis. Families Does not necessitate any involvement of families. The first they may know is when they are called to come and collect the body; assumes that an assisted death is 'better' than a well-managed natural death but there is little or no evidence in the literature for this assertion. Palliative care Makes it a legal right for patients to access assisted dying, but does not mandate a comparable right to be able to access other end of life services; means that patients may choose assisted dying because palliative care provision is inadequate • Places palliative care consultants (a speciality in which 80% of doctors are opposed to assisted dying) at the heart of delivering the services; ignores the fact that the UK is currently ranked higher for its palliative care services than any country that delivers assisted dying and the fact that countries that introduce assisted dying almost invariably see a decline in the quality of their palliative care services. The medical workforce Does not adequately recognise the risk of harm to doctors from delivering assisted dying; is unclear whether assisted dying should be considered a 'treatment'. Provision of adequate care Proposes a panel which is not a multidisciplinary team and will not know the patient; proposes use of drugs which are not regulated or approved and does not mandate any monitoring of their complications.

World must ‘start screening for prostate cancer to stop men being left behind'
World must ‘start screening for prostate cancer to stop men being left behind'

Telegraph

timean hour ago

  • Telegraph

World must ‘start screening for prostate cancer to stop men being left behind'

Every country should have a strategy for tackling prostate cancer with dedicated screening programs for men over 50, a leading health charity has said. Global Action on Men's Health, the leading international charity for men's health, is calling for prostate cancer – now the third most common cancer worldwide – to be dramatically elevated on the health agenda. On Monday it will launch a campaign to encourage all countries with adequate resources, including the UK, to launch national screening for the disease in a bid to cut unnecessary deaths. It will also call for the World Health Organization (WHO) to introduce a Global Prostate Cancer Initiative which 'covers every stage of the prostate cancer pathway from prevention to palliative care'. Prostate cancer is now the most frequently diagnosed cancer in men in 112 countries and the leading cause of cancer death among men in 48 countries. In England, it is now the most common cancer, killing some 12,000 men every year, according to Prostate Cancer UK. Writing in today's Telegraph, Peter Baker, the director of Global Action on Men's Health, said that men were being short-changed when it comes to healthcare. 'Men's health has been neglected for far too long with devastating consequences,' he writes. 'Globally, men's life expectancy lags five years behind women's. Men are significantly more likely to develop and die from cancer, heart disease, diabetes and tuberculosis. They are also at much greater risk of dying from suicide or an accident on the roads or at work.' Mr Baker calls for reform across health care systems – ensuring men have better access to GPs, for instance – and believes that a focus on prostate cancer is a good place to start. Rapid advances in screening technologies now mean that developed nations should soon be able to launch screening programs that will cut death rates by a third or more and reduce the dramatic social inequalities associated with the disease. Men with a family history of prostate cancer run a significantly higher genetic risk of developing prostate cancer, as do black men. Men from lower socioeconomic backgrounds are also much harder hit, due to a combination of poor health literacy and access to healthcare. The European Commission recently recommended introducing national prostate cancer screening across all 27 member states of the European Union, and already countries including Sweden and Norway have either launched or are on the brink of launching national screening programs. While blood tests for prostate cancer, known as prostate-specific antigen tests (PSA), have been available for many years, they throw up a large number of false positives. This in turn led to many unnecessary prostate removals and biopsies being performed, meaning the risks outweighed the benefits of running national screening programmes. But now, with the advent of more specific blood tests and high resolution MRI scans, which allow for much more accurate biopsies, the balance has changed, with several high quality studies showing the benefit of screening. The largest of these studies was the European Randomised Study of Screening for Prostate Cancer (ERSPC), which included over 182,000 men and showed a 20 per cent reduction in prostate cancer mortality among those screened. Another study in Gothenburg, Sweden, found that after 18 years of follow-up, men in the screening group were 35 per cent less likely to die from prostate cancer than men who were not screened. Men who started screening at age 55-59 were 53 per cent less likely to die. Professor Jonas Hugosson, a urologist at University of Gothenburg in Sweden who led the Swedish study, said he expected national screening for prostate cancer to be rolled out across most western European nations in the next few years. In Sweden a move to nationwide screening was already progressing and in Norway he expected a national screening program to be announced shortly, he said. However, just as with the roll out of breast cancer screening more than three decades ago, it would take most countries many years to gear up. 'In my view, we have quite a new situation today, and I think it's time for the health authorities to take a new standpoint,' he said. 'I'm quite sure about that and we will see screening come all over Europe during the coming years, but it takes 10 years to build up, at least.' 'Alarming and unacceptable' rise in cases The NHS in England does not have a dedicated men's health strategy but one has been promised by the end of the year by the new Health Secretary, Wes Streeting. Although the new strategy is unlikely to include the imminent launch of a national screening program for prostate cancer – the UK currently does not have the MRI machines and trained staff needed to launch one – it may include screening for high risk groups. These include black men, who have double the normal risk, and men with a family history of prostate and related cancers – including breast and ovarian cancer on the female side. In October last year, six-time Olympic cycling champion Sir Chris Hoy, 49, revealed that he had terminal prostate cancer. Both his father and grandfather had the disease but his was not caught by early testing, sparking an outcry. 'The rapid rise in prostate cancer cases is not just alarming, it is also unnecessary and therefore unacceptable,' said Global Action on Men's Health. 'Prostate cancer is currently inadequately addressed in global and national cancer policies'. In addition to national testing where possible, the charity is calling for the WHO to support a new Global Prostate Cancer Initiative covering 10 areas. These include governments being urged to introduce national cancer plans which specifically address prostate cancer with clear performance indicators, education programmes to raise awareness and tackle stigma, and investments in research, infrastructure, workforce development and treatments for prostate cancer. The WHO does not currently have a programme that focuses specifically on prostate cancer but 'integrates' it to its wider program for tackling cancer more generally. Cervical cancer, in contrast, has a dedicated programme dedicated to its global eradication but that is because the HPV vaccine makes it possible to wipe out the disease completely. Dr André Ilbawi, technical lead for cancer control at the WHO, welcomed the prostate campaign launched by Global Action on Men's Health, and said the disease was moving up the WHO's agenda. The organisation had just five countries involved in its cancer programme in 2015 to but has 100 today. 'We see prostate cancer as a priority and, in 2023, elevated it in our guidance because it can be treated,' said Dr IIbawi. 'If treatment is available, survival is extremely high. And if treatments are not available, those men will die. 'We agree that prostate cancer should be seen in the cancer agenda as high impact, cost-effective and meeting community needs'.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store